Anne‐Lise Børresen‐Dale

27.6k citations

26 papers · 12.4k indexed · 1 hit paper · h-index 18

Molecular Biology top 0.5%
Cancer Research top 0.1%
Oncology top 0.2%
Pulmonary and Respiratory Medicine top 1%
Genetics top 1%

Co-authors: Thérese Sørlie Hilde Johnsen Per Eystein Lønning Charles M. Perou Michael B. Eisen Shirley Zhu Patrick O. Brown David Botstein
Topics: Cancer Genomics and Diagnostics (10 papers)Gene expression and cancer classification (6 papers)Breast Cancer Treatment Studies (5 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Nucleic Acids Research PLoS ONE
Partner nations: Norway United States United Kingdom

In The Last Decade

Anne‐Lise Børresen‐Dale

25 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular portraits of human breast tumours

2000 11.7k citations Charles M. Perou, Thérese Sørlie et al. Nature profile →

Peers

Countries citing papers authored by Anne‐Lise Børresen‐Dale

Since Specialization

Citations

This map shows the geographic impact of Anne‐Lise Børresen‐Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen‐Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen‐Dale more than expected).

Fields of papers citing papers by Anne‐Lise Børresen‐Dale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen‐Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen‐Dale. The network helps show where Anne‐Lise Børresen‐Dale may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen‐Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen‐Dale. A scholar is included among the top collaborators of Anne‐Lise Børresen‐Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen‐Dale. Anne‐Lise Børresen‐Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers 2022 ·Nucleic Acids Research ·Jaime A. Castro-Mondragón,Miriam R. R. Aure,Ole Christian Lingjærde,Anita Langerød,John W.M. Martens,Anne‐Lise Børresen‐Dale,Vessela N. Kristensen,Anthony Mathelier	10
2	PathTracer: High-sensitivity detection of differential pathway activity in tumours 2019 ·Scientific Reports ·Ståle Nygård,Ole Christian Lingjærde,Carlos Caldas,Eivind Hovig,Anne‐Lise Børresen‐Dale,Åslaug Helland,Vilde Drageset Haakensen	2
3	Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations 2018 ·Genome Medicine ·Elen Höglander,Silje Nord,David C. Wedge,Ole Christian Lingjærde,Laxmi Silwal‐Pandit,(unknown),Hans Kristian Moen Vollan,Thomas Fleischer,Marit Krohn,(unknown),Elin Borgen,Øystein Garred,Marit Muri Holmen,Erik Wist,Bjørn Naume,Peter Van Loo,Anne‐Lise Børresen‐Dale,Olav Engebraaten,Vessela N. Kristensen	18
4	Abstract A101: The MetAction trial: long-lasting responses to molecularly matched therapy in end-stage cancer 2018 ·Molecular Cancer Therapeutics ·Anne Hansen Ree,Kjersti Flatmark,Vigdis Nygaard,Daniel Heinrich,Kjetil Boye,Svein Dueland,Vegard Nygaard,Eivind Hovig,Klaus Beiske,Marius Lund‐Iversen,Viví Ann Flørenes,(unknown),(unknown),(unknown),Sigve Nakken,Gry Aarum Geitvik,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale,Hege G. Russnes,Gunhild M. Mælandsmo	0
5	Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases 2017 ·Oncotarget ·Oľga Østrup,Vegar Johansen Dagenborg,Einar Andreas Rødland,(unknown),Laxmi Silwal‐Pandit,Krzysztof Grzyb,A. Berstad,Åsmund Avdem Fretland,Gunhild M. Mælandsmo,Anne‐Lise Børresen‐Dale,Anne Hansen Ree,Bjørn Edwin,Vigdis Nygaard,Kjersti Flatmark	25
6	Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy 2016 ·PubMed ·Kurt S. Zänker,Anne‐Lise Børresen‐Dale,(unknown)	2
7	Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study 2014 ·BMC Cancer ·(unknown),Marte K. Viken,Anders Erik Astrup Dahm,Hans Kristian Moen Vollan,Kristine Kleivi Sahlberg,Øystein Garred,Anne‐Lise Børresen‐Dale,Anne Flem Jacobsen,Vessela N. Kristensen,Ida Bukholm,Rolf Kåresen,Ellen Schlichting,Grethe Skretting,Benedicte A. Lie,Per Morten Sandset,Nina Iversen	34
8	Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas 2014 ·Molecular Oncology ·(unknown),Inger Marie Bowitz Lothe,Knut Jørgen Labori,Ole Christian Lingjærde,Trond Buanes,(unknown),(unknown),Julian Hamfjord,Terese Haaland,T. J. Eide,Anne‐Lise Børresen‐Dale,Tone Ikdahl,Elin H. Kure	32
9	Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status 2014 ·BMC Cancer ·Xi Zhao,Einar Andreas Rødland,Thérese Sørlie,Hans Kristian Moen Vollan,Hege G. Russnes,Vessela N. Kristensen,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale	31
10	Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer 2013 ·Breast Cancer Research and Treatment ·Yanhong Liu,Renke Zhou,Lars O. Baumbusch,Spyros Tsavachidis,(unknown),Kim‐Anh Do,Ayşegül A. Şahin,Gabriel N. Hortobágyi,Joseph H. Taube,Sendurai A. Mani,Jørgen Aarøe,Fredrik Wärnberg,Anne‐Lise Børresen‐Dale,Gordon B. Mills,Patricia A. Thompson,Melissa L. Bondy	8
11	High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival 2013 ·PLoS ONE ·Lars O. Baumbusch,Åslaug Helland,Yun Wang,Knut Liestøl,Marci E. Schaner,Ruth Holm,Dariush Etemadmoghadam,Kathryn Alsop,Pat Brown,(unknown),Gillian Mitchell,Sián Fereday,Anna DeFazio,David D.L. Bowtell,Gunnar B. Kristensen,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale	17
12	Next-Generation Sequencing of Disseminated Tumor Cells 2013 ·Frontiers in Oncology ·(unknown),Parveen Kumar,Thierry Voet,(unknown),Peter Van Loo,Randi R. Mathiesen,(unknown),Jason Grundstad,Elin Borgen,Lars O. Baumbusch,Bjørn Naume,Anne‐Lise Børresen‐Dale,Kevin P. White,Silje Nord,Vessela N. Kristensen	29
13	Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features 2011 ·BMC Medical Genomics ·Vilde Drageset Haakensen,Ole Christian Lingjærde,Torben Lüders,Margit Riis,Aleix Prat,Melissa A. Troester,Marit Muri Holmen,(unknown),(unknown),(unknown),I. K. Bukholm,Tom Børge Johannesen,Charles M. Perou,Giske Ursin,Vessela N. Kristensen,Anne‐Lise Børresen‐Dale,Åslaug Helland	29
14	High‐resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer 2011 ·International Journal of Cancer ·Randi R. Mathiesen,(unknown),Knut Liestøl,Eldri U. Due,Jochen B. Geigl,Sabine Riethdorf,Elin Borgen,Inga Hansine Rye,(unknown),Anna C. Obenauf,Oliver Mauermann,Gro Nilsen,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale,Klaus Pantel,Michael R. Speicher,Bjørn Naume,Lars O. Baumbusch	44
15	Merging transcriptomics and metabolomics - advances in breast cancer profiling 2010 ·BMC Cancer ·Eldrid Borgan,Beathe Sitter,Ole Christian Lingjærde,Hilde Johnsen,Steinar Lundgren,Tone F. Bathen,Thérese Sørlie,Anne‐Lise Børresen‐Dale,Ingrid S. Gribbestad	92
16	Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density 2010 ·Breast Cancer Research ·Vilde Drageset Haakensen,(unknown),Ole Christian Lingjærde,Marit Muri Holmen,(unknown),Ying Chen,(unknown),(unknown),Torben Lüders,I. K. Bukholm,Hiroko Kato Solvang,Vessela N. Kristensen,Giske Ursin,Anne‐Lise Børresen‐Dale,Åslaug Helland	38
17	Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications 2005 ·Clinical Cancer Research ·Vessela N. Kristensen,Thérese Sørlie,Jürgen Geisler,Anita Langerød,Noriko Yoshimura,Rolf Kåresen,Nobuhiro Harada,Per Eystein Lønning,Anne‐Lise Børresen‐Dale	25
18	High‐resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas 2004 ·Genes Chromosomes and Cancer ·Magdalena Benetkiewicz,Yun Wang,Marci E. Schaner,Pei Wang,Kiran K. Mantripragada,Patrick G. Buckley,Gunnar B. Kristensen,Anne‐Lise Børresen‐Dale,Jan P. Dumanski	24
19	Molecular portraits of human breast tumoursbreakdown → 2000 ·Nature ·Charles M. Perou,Thérese Sørlie,Michael B. Eisen,Matt van de Rijn,Stefanie S. Jeffrey,Christian A. Rees,Jonathan R. Pollack,Douglas T. Ross,Hilde Johnsen,Lars A. Akslen,Øystein Fluge,Alexander Pergamenschikov,(unknown),Shirley Zhu,Per Eystein Lønning,Anne‐Lise Børresen‐Dale,Patrick O. Brown,David Botstein	11684
20	Screening for ESR mutations in breast and ovarian cancer patients 1997 ·Human Mutation ·Tone Ikdahl Andersen,Richard Wooster,(unknown),Nadine Collins,William Warren,Martina L. Skrede,(unknown),Kjell M. Tveit,Stephen Johnston,Mitch Dowsett,Anne O. Olsen,Pål Møller,Mike Stratton,Anne‐Lise Børresen‐Dale	3

About Anne‐Lise Børresen‐Dale

Anne‐Lise Børresen‐Dale is a scholar working on Cancer Research, Oncology and Internal Medicine, having authored 26 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Gene expression and cancer classification (6 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Cancer Research (6.1k citations), Oncology (6.0k citations) and Molecular Biology (6.3k citations). Anne‐Lise Børresen‐Dale has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Thérese Sørlie, Hilde Johnsen, Per Eystein Lønning, Charles M. Perou, Michael B. Eisen, Shirley Zhu, Patrick O. Brown, David Botstein, Lars A. Akslen and Douglas T. Ross. Their work appears in journals such as Nature, Nucleic Acids Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact